Radiosynthesis and quality control testing of two <sup>18</sup>F-labeled radiopharmaceuticals for α-synuclein imaging in clinical investigations. [PDF]
Hashimoto H +15 more
europepmc +1 more source
Assessment of PET drug adverse events in the U.S. since the implementation of 21 CFR part 212. [PDF]
Dakanali M +3 more
europepmc +1 more source
Breastfeeding Interruption and Resumption: A Risk-Based Clinical Decision Framework. [PDF]
Petroaie AD +8 more
europepmc +1 more source
Global burden of pain in malignant bone tumors: a meta-analysis of severity and health outcomes. [PDF]
Zheng G +5 more
europepmc +1 more source
Editorial for the Special Issue "Research on Radiotracers and Novel Radiopharmaceuticals for Cancer Therapy and Diagnosis". [PDF]
Shegani A.
europepmc +1 more source
Future scenarios of radioligand therapy in pheochromocytomas and paragangliomas. [PDF]
Pacella S +6 more
europepmc +1 more source
Editorial: Advances in PET-CT imaging, vol. II. [PDF]
Santo G, Gazzilli M, Dondi F.
europepmc +1 more source
Dopaminergic Radiopharmaceutical Imaging in Parkinsonian Syndromes: From Molecular Targets to Clinical Decision-Making. [PDF]
Jalloul W +7 more
europepmc +1 more source
Modified Reaction Conditions for the Radiosynthesis of <sup>11</sup>C‑Labeled Asymmetrical Guanidines and the Automated Radiosynthesis of a [<sup>11</sup>C]<i>m</i>IBG Analog. [PDF]
Witek JA +8 more
europepmc +1 more source
Editorial: Expert opinions and viewpoints in nuclear medicine. [PDF]
Treglia G.
europepmc +1 more source

